工程人类iPS细胞模型揭示了与CHD相关的SMAD2突变中改变的 podocytogenesis 和 glomerular毛细管壁
bioRxiv : the preprint server for biology
|August 30, 2024
概括
与先天性心脏病 (CHD) 相关的SMAD2基因变异破坏脏发育. 这项研究揭示了这些SMAD2突变如何损害细胞的形成和功能,这可能解释了CHD患者的多器官问题.
科学领域:
- 发展生物学 发展生物学
- 遗传学 遗传学 是一个
- 腎臟病學 (nephrology) 是一種醫學.
背景情况:
- 先天性心脏病 (CHD) 与多器官功能障碍有关.
- 患有心脏病和SMAD2变异的患者经常表现出脏问题,如血球硬化和白尿.
- SMAD2变异对发育的直接影响尚不清楚.
研究的目的:
- 为了研究致病性SMAD2变异在脏细胞生成中的作用.
- 为了确定与心脏病相关的SMAD2变异是否直接影响细胞命运和功能.
- 使用人类诱导的多能干细胞 (iPSC) 和芯片器官系统来建模发育.
主要方法:
- 设计了人类iPSC来模拟SMAD2变体.
- 使用了芯片上的器官系统,包括芯片上的淋巴细胞平台.
- 差异化的iPSC检查细胞系的发展和细胞的形成.
主要成果:
- 废除SMAD2改变的间皮和中间间皮 (IM) 细胞模式.
- 来自IM细胞的突变细胞未能发展出适当的树木化和数字化.
- 芯片上的球体模型显示出显著的蛋白尿,反映了临床观察.
结论:
- 与CHD相关的SMAD2突变在发育过程中直接影响脏组织形.
- SMAD2在细胞系特异化和细胞分化中发挥着关键作用.
- 这项研究提供了关于心脏病脏缺陷背后的机制以及潜在的治疗点的见解.
相关概念视频
iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


